Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.66 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | DRD1 | P21728 | 2/20 | 0.44 |
| ▸ | DRD5 | P21918 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13437764 | 0.92 | SETD7 (0.54) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL13437756 | 0.91 | SETD7 (0.54) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL13462520 | 0.87 | NPC1 (0.50) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL13437752 | 0.86 | SETD7 (0.48) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL14627509 | 0.83 | SETD7 (0.45) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL27508978 | 0.82 | OPRM1 (0.45) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL9253170 | 0.81 | OPRM1 (0.48) | SETD7OPRD1OPRM1ALDH1A1NPC1 | |
| SCHEMBL4079255 | 0.81 | SETD7 (1.00) | SETD7OPRD1OPRM1DRD2DRD3 | |
| SCHEMBL13437761 | 0.80 | CTNNB1 (0.49) | SETD7DRD2DRD3DRD1DRD5 | |
| SCHEMBL13437757 | 0.77 | LMNA (0.50) | SETD7OPRD1OPRM1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683077-B2 | Piperidine derivative | AJINOMOTO CO., INC. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20070021460-A1 | Novel piperidine derivative | AJINOMOTO CO., INC. (JP) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021460-A1 | Novel piperidine derivative | HTR7, TPH1, HTR5A | SETD7 142/4885OPRD1 38/4885OPRM1 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.